Beihai Gofar Chuanshan Biological Management
Management criteria checks 2/4
Beihai Gofar Chuanshan Biological's CEO is Bin Pan Li, appointed in Sep 2009, has a tenure of 15.33 years. directly owns 1.64% of the company’s shares, worth CN¥43.53M. The average tenure of the management team and the board of directors is 15.3 years and 7.7 years respectively.
Key information
Bin Pan Li
Chief executive officer
CN¥1.8m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 15.3yrs |
| CEO ownership | 1.6% |
| Management average tenure | 15.3yrs |
| Board average tenure | 7.7yrs |
Recent management updates
Recent updates
Optimistic Investors Push Beihai Gofar Chuanshan Biological Co., Ltd. (SHSE:600538) Shares Up 32% But Growth Is Lacking
Oct 18
Investor Optimism Abounds Beihai Gofar Chuanshan Biological Co., Ltd. (SHSE:600538) But Growth Is Lacking
Jul 12Beihai Gofar Chuanshan Biological Co., Ltd.'s (SHSE:600538) Shares Climb 34% But Its Business Is Yet to Catch Up
Mar 08CEO
Bin Pan Li (59 yo)
15.3yrs
Tenure
CN¥1,847,100
Compensation
Dr. Bin Pan Li serves as the Chairman of Beihai Gofar Chuanshan Biological Co., Ltd. (formerly known as Beihai Gofar Marine Biological Industry Co., Ltd.) since February 2, 2010 and has been its Director a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 15.3yrs | CN¥1.85m | 1.64% CN¥ 43.5m | |
| CFO, VP & Director | 14.7yrs | CN¥1.00m | no data | |
| Secretary | 23.8yrs | CN¥941.60k | no data | |
| Accounting Supervisor | no data | no data | no data |
15.3yrs
Average Tenure
59yo
Average Age
Experienced Management: 600538's management team is seasoned and experienced (15.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 15.3yrs | CN¥1.85m | 1.64% CN¥ 43.5m | |
| CFO, VP & Director | 14.3yrs | CN¥1.00m | no data | |
| Secretary | 16.8yrs | CN¥941.60k | no data | |
| Director | 3.7yrs | CN¥80.00k | 0.66% CN¥ 17.5m | |
| Independent Director | 1.7yrs | CN¥41.70k | no data | |
| Director | 10.8yrs | CN¥80.00k | no data | |
| Director | 3.7yrs | CN¥80.00k | 0.67% CN¥ 17.7m | |
| Independent Director | 4.7yrs | CN¥100.00k | no data | |
| Independent Director | 4.7yrs | CN¥100.00k | no data | |
| Chairman of the Supervisory Board | 7.7yrs | no data | no data | |
| Supervisor | 7.7yrs | no data | no data | |
| Employee Supervisor | 13.8yrs | no data | no data |
7.7yrs
Average Tenure
51.5yo
Average Age
Experienced Board: 600538's board of directors are considered experienced (7.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/04 23:01 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Beihai Gofar Chuanshan Biological Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|